Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
NCT01279798
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL:
Lucanix® (belagenpumatucel-L)
Sponsor
NovaRx Corporation